MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

P. Kashyap, S. Gupta (Bihar, India)

Meeting: 2018 International Congress

Abstract Number: 828

Keywords: Behavioral abnormalities, Catalase, Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis

Session Information

Date: Sunday, October 7, 2018

Session Title: Huntington's Disease

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: The present study examined the potential therapeutic effects of CA against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD and explored the mechanisms of action.

Background: Huntington’s disease (HD) is a neurodegenerative disorder characterized by symptoms like chorea and dementia, results from the destruction of neurons in the basal ganglia, and oxidative stress has been implicated in its pathogenesis. Cinnamaldehyde (CA) is a diterpene with a wide range of anti-inflammatory, cognitive enhancer, neuroprotective, anti-diabetic effects thus may be advantageous in the treatment of neurological disease.

Methods: 50 Male SD rats were pretreated with CA (20 and 40 mg/kg b.w.) orally prior to the intraperitoneally (i.p.) administration of 3-NP (12 mg/kg b.w.) for 15 days. Nimodipine (12 mg/kg, po) was used as positive control drugs. The body weight, grip strength and behavior were monitored within 5th, 10th and 15th day after 3-NP treatment. Then the animals were sacrificed, neuronal damage in striatum was estimated using Nissl staining. Hsp70 expression was detected with immunohistochemistry. Reactive oxygen species (ROS) generation was measured using dihydroethidium (DHE) staining. Memory (Morris water maze) , antioxidants enzymes and lipid peroxides were analyzed in rat model of HD.

Results: Present results shown that administration of 3-NP resulted in a marked reduction in the body weight, memory, grip strength locomotion activity and significantly increased lipid peroxidation and depleted antioxidant enzyme accompanied by progressive striatal dysfunction. CA (20 and 40 mg/kg) treated animals exhibited a significant (p < 0.01) improvement in behavioural, biochemical, histological alterations and oxidative stress parameters in comparison to only 3-NP treated animals. Present results shown dose-dependently improved 3-NP-induced behavioral, biochemical, and enzymatic changes (P < .001). Similar effects were obtained with the positive control drugs nimodipine.

Conclusions: CA exerts a protective action against 3-NP-induced oxidative stress in the rat model of HD, which is associated with its anti-oxidant activity, and consequently improves behavioral deficits.

To cite this abstract in AMA style:

P. Kashyap, S. Gupta. Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotective-role-of-cinnamaldehyde-against-3-nitropropionic-acid-induced-oxidative-stress-in-a-rat-model-of-huntingtons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-role-of-cinnamaldehyde-against-3-nitropropionic-acid-induced-oxidative-stress-in-a-rat-model-of-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley